"Yaosu Technology" has completed a new round of strategic financing worth tens of millions of yuan.
36Kr has learned that recently, Xellar announced the completion of a new round of strategic financing worth tens of millions of yuan. This round of financing is backed by relevant investment entities including Shanghai SDIC Pilot Fund, CSPC Guofang Fund and other related investment institutions. The funds raised in this round will be mainly used for the continuous construction of the "3D Bio Intelligence" platform, further integrating organ-on-a-chip, artificial intelligence and automated experimental technologies, accelerating the accumulation of high-quality humanized biological data, biological mechanism analysis and AI model capability building, and promoting the continuous upgrading of bio-intelligent infrastructure oriented to next-generation drug R&D.